Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

1.43 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -165.867-292.191-237.113-166.093-118.548-46.378-23.432
Depreciation & Amortization 1.2891.3891.4260.5440.160.1110.051
Deferred Income Tax 0-0.853-0.769-2.4620.0177.7762.365
Stock Based Compensation 67.26954.82246.8435.73723.1460.6170.308
Change In Working Capital -16.545.86413.25216.5577.8446.507-1.178
Accounts Receivables -5000.413-0.2770.777-0.254
Inventory 0000.881-5.519-1.508-1.861
Accounts Payables -18.02210.91915.52713.91614.3077.1230.977
Other Working Capital 6.482-5.055-2.2751.347-0.6670.115-0.04
Other Non Cash Items -57.01123.14712.613-38.3760.556-7.776-2.365
Operating Cash Flow -170.86-207.822-163.751-154.093-86.825-39.143-24.251
Investing Activities:
Investments In Property Plant And Equipment -0.221-0.583-2.548-6.107-0.758-0.352-0.227
Acquisitions Net 000.112-14.3218.42400
Purchases Of Investments -127.962-549.182-533.161-363.508-400.98400
Sales Maturities Of Investments 304.679505.307421.529365.82116.9100
Other Investing Activites 0.0650-0.112-0.012-18.42400
Investing Cash Flow 176.561-44.458-114.18-18.115-284.832-0.352-0.227
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 0.349237.303261.043179.667327.78781.830.016
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -0.24100-1.14632.65281.839.456
Financing Cash Flow 0.108237.303261.043178.521360.43981.839.472
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 5.809-14.977-16.8886.313-11.21842.335-15.006
Cash At End Of Period 36.52830.71945.69662.58456.27167.48925.154